{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:15:20Z","timestamp":1773659720591,"version":"3.50.1"},"reference-count":44,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T00:00:00Z","timestamp":1039564800000},"content-version":"vor","delay-in-days":40,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology International"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p>Our previous immunohistochemical studies in the pancreas, intrahepatic bile duct, and ampulla of Vater demonstrated that an invasive carcinoma with a poor outcome showed a pattern of MUC1 (membrane\u2010bound mucin) positive and MUC2 (intestinal\u2010type secretory mucin) negative, whereas many of the non\u2010invasive tumors with favorable outcome showed a pattern of MUC1 negative and MUC2 positive. The aim of this study is to compare the expression profiles of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas to gain insight into the relationship between the biological nature of the carcinomas and the role of mucins. We examined the expression profiles of MUC1 of different glycoforms and MUC2 in 60 extrahepatic bile duct carcinomas using immunohistochemistry. The expression of MUC1\/CORE (core peptide of MUC1), MUC1\/DF3 (core peptide of MUC1 with sialyl oligosaccharides) and MUC1\/MY.1E12 (sialylated MUC1) showed a significant relationship with tumor progression factors such as poor differentiation, deep invasion, lymph node metastasis, lymphatic invasion or perineural invasion. In contrast, the expression of MUC1\/HMFG\u20101 (fully glycosylated MUC1) did not show a significant relationship with the tumor progression factors. In the different glycoforms of MUC1 examined, the expression of MUC1\/DF3 and MUC1\/MY.1E12 was related with the poor outcome of the patients. In contrast, the expression of MUC2 was inversely related with the tumor progression factors and poor outcome. In the 52 patients with advanced tumors, only MUC1\/DF3 high expression correlated with poor prognosis. In conclusion, MUC1\/DF3 was the most useful prognosis indicator among the various glycoforms of MUC1 mucins.<\/jats:p>","DOI":"10.1046\/j.1440-1827.2002.01414.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T17:18:23Z","timestamp":1047489503000},"page":"713-723","source":"Crossref","is-referenced-by-count":66,"title":["Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis"],"prefix":"10.1111","volume":"52","author":[{"given":"Shugo","family":"Tamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuharu","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadao","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koro","family":"Sakoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohzo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,12,11]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(199703)64:3<242::AID-JSO12>3.0.CO;2-6"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800831217"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1989.01410020122021"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930401)71:7<2191::AID-CNCR2820710705>3.0.CO;2-X"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910550116"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1996.tb00270.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300609"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.282"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)58460-X"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(97)00317-8"},{"key":"e_1_2_6_12_2","first-page":"4083","article-title":"Two novel mucin genes down\u2010regulated in colorectal cancer identified differential display","volume":"59","author":"Williams SJ","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008850200"},{"key":"e_1_2_6_14_2","first-page":"55","article-title":"Tissue and tumor distribution of human polymorphic epithelial mucin","volume":"11","author":"Zotter S","year":"1988","journal-title":"Cancer Rev."},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90057-4"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2001.01291.x"},{"key":"e_1_2_6_17_2","first-page":"261","article-title":"Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT\u201020 human breast carcinoma cell line","volume":"1","author":"Hull SR","year":"1989","journal-title":"Cancer Commun."},{"key":"e_1_2_6_18_2","first-page":"2605","article-title":"Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with the prognosis of the patients","volume":"4","author":"Utsunomiya T","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90592-4"},{"key":"e_1_2_6_20_2","volume-title":"TNM Classification of Malignant Tumors","author":"Sobin LH","year":"1997"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.7.2320"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1996.tb00250.x"},{"key":"e_1_2_6_23_2","first-page":"155","article-title":"Effect of modification of carbohydrate side chains on the reactive of antibodies with core\u2010protein epitopes of the MUC1 gene product","volume":"2","author":"Burchell J","year":"1993","journal-title":"Epith. Cell Biol."},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910280104"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.131.1.508"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)83373-7"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1109"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(94)90144-9"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.1999.00823.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1267\/ahc.28.239"},{"key":"e_1_2_6_31_2","first-page":"2318","article-title":"Suppression of cellular aggregation by high level of episialin","volume":"52","author":"Ligtenberg MJL","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1996.tb00252.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.151.2.767","article-title":"Episialin (MUC1) inhibits cytotoxic lymphocyte\u2013target cell interaction","volume":"151","author":"Van De Wiel\u2010van Kemenade E","year":"1993","journal-title":"J. Immunol."},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.129.1.255"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<377::AID-IJC15>3.0.CO;2-8"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.7.4.565"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.4.519"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.4052\/tigg.7.31"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910380620"},{"key":"e_1_2_6_40_2","first-page":"6800","article-title":"Sialomucin and lytic susceptibility of rat mammary tumor ascites cells","volume":"50","author":"Moriarty J","year":"1990","journal-title":"Cancer Res."},{"key":"e_1_2_6_41_2","first-page":"4741","article-title":"Mucins bearing the cancer\u2010associated sialosyl\u2010Tn antigen mediated inhibition of natural killer cell cytotoxicity","volume":"52","author":"Ogata S","year":"1992","journal-title":"Cancer Res."},{"key":"e_1_2_6_42_2","first-page":"3331","article-title":"Soluble factor in normal tissues that simulates high molecular weight sialoglycoprotein produced by human colon carcinoma cells","volume":"50","author":"Irimura T","year":"1990","journal-title":"Cancer Res."},{"key":"e_1_2_6_43_2","first-page":"319","article-title":"Colorectal cancer metastasis determined by carbohydrate\u2010mediated cell adhesion: Role of sialyl\u2010Lex antigens","volume":"4","author":"Irimura T","year":"1993","journal-title":"Semin. Cancer Biol."},{"key":"e_1_2_6_44_2","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/S0021-9258(17)41965-X","article-title":"Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to pre\u2010pro\u2010von Willebrand factor","volume":"269","author":"Gum JR","year":"1994","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115360"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1827.2002.01414.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1827.2002.01414.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T21:34:46Z","timestamp":1697492086000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1827.2002.01414.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1046\/j.1440-1827.2002.01414.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1827.2002.01414.x","archive":["Portico"],"relation":{},"ISSN":["1320-5463","1440-1827"],"issn-type":[{"value":"1320-5463","type":"print"},{"value":"1440-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}